scispace - formally typeset
Search or ask a question

What is the embryology of prostate gland? 


Best insight from top research papers

The prostate gland develops during embryonic development and continues to grow through puberty. It originates from epithelial invaginations from the posterior urogenital sinus under the influence of the underlying mesenchyme . The development of the prostate gland is regulated by androgens and involves cell-cell communication between the epithelium and mesenchyme . The prostate gland and Cowper's gland develop from the urogenital sinus, while the seminal vesicles, vas deferens, ejaculatory duct, and epididymis originate from the mesonephric ducts . The urethra runs through the prostate gland, which is lined by transitional epithelium and encircled by sphincteric muscles . Prostatic budding begins around the tenth week of gestation and is induced by surrounding mesenchyme and hormonal effects . The development of the prostate gland requires the presence of 5α-dihydrotestosterone, synthesized from fetal testosterone by the action of 5α-reductase .

Answers from top 5 papers

More filters
Papers (5)Insight
The paper provides a comprehensive overview of prostate development, focusing on sexual dimorphism, bud induction, branching morphogenesis, and cellular differentiation. However, it does not specifically discuss the embryology of the prostate gland.
During the third month of gestation, the prostate gland develops from epithelial invaginations from the posterior urogenital sinus under the influence of the underlying mesenchyme.
The paper provides information on the embryology of the prostate gland. According to the paper, the morphogenesis of the prostate begins at 9-10 weeks of gestation and is only completed at sexual maturity.
The prostate gland develops from the urogenital sinus, and its growth is induced by surrounding mesenchyme and hormonal effects.
Journal ArticleDOI
A. Pletcher, Maho Shibata 
15 Jun 2022-Development
2 Citations
The paper discusses the embryonic development of the prostate gland and its regulation by androgens and cell-cell communication between the epithelium and mesenchyme.

Related Questions

How happen the ontogenesis of pituitary gland ?5 answersThe ontogenesis of the pituitary gland involves intricate developmental processes. During early life, the embryogenesis of the hypothalamo-pituitary unit is completed, with the hypothalamo-hypophyseal portal system forming. Transcription factors like Pit-1, Prop-1, and others play crucial roles in pituitary development, with Pit-1 gene alterations linked to hypopituitarism in humans. In human embryos, Rathke's pouch gives rise to different parts of the pituitary, including the anterior lobe and pars distalis, through complex morphogenetic changes. The intermediate lobe of the pituitary in rabbits undergoes differentiation, with melanotrophic cells appearing and innervation stimulating their synthetic activity. In primates, the fetal adrenal gland's zones develop at different gestational stages, with ACTH influencing the transitional zone's growth late in gestation. These findings collectively highlight the multifaceted ontogenesis of the pituitary gland involving genetic, morphological, and hormonal influences.
What are the cells that compounds the prostate ?4 answersThe prostate is composed of two main cell populations: luminal epithelial cells and basal epithelial cells. Luminal cells have a secretory function and support male fertility, while basal cells are involved in regeneration and maintenance of the epithelial tissue. In addition to these two cell types, there are also neuroendocrine cells present in the prostate. Stem cells are another important component of the prostate, with both epithelial stem cells and mesenchymal stem cells identified in this tissue. Epithelial stem cells express markers such as cytokeratin, stem cell antigen-1, and integrins alpha2beta1, CD49f, CD133, CD117, and CD44, while mesenchymal stem cells express markers like CD30, CD44, CD133, neuron-specific enolase, and vascular endothelial growth factor receptor-1. These stem cells play a role in the development and treatment of prostatic diseases.
How is prostate cancer defined?4 answersProstate cancer is a common cancer among men and is defined as the development of malignant tumors in the prostate gland. It is the most frequently occurring cancer in adult males and is associated with various risk factors such as older age, black ethnicity, family history of the disease, increased body mass index, and obesity. Diagnosis of prostate cancer is based on ultrasound, MRI, biopsies, and exams to assess cancer stage and spread. Treatment options for prostate cancer include surgery, radiotherapy, hormone therapy, immunotherapy, and palliative care. The growth of prostate cancer cells is regulated by critical signaling pathways such as mTOR/AKT/PI3K and ERK/MEK/Raf/Ras. Gene mutations, such as mutations in the PTEN gene, can play a significant role in the development of prostate cancer. Prostate cancer can range from indolent disease managed with surveillance to aggressive malignancy requiring multidisciplinary treatment.
What is the embryo?3 answersThe definition of the embryo varies depending on the perspective and context. From a biological standpoint, the embryo is a developing human individual from the time of implantation to the end of the eighth week after conception. It is a discrete entity that arises from the first mitotic division after fertilization of a human oocyte by a human sperm or any other process that initiates organized development of a biological entity with a human nuclear genome or altered human nuclear genome. However, the concept of the embryo goes beyond biology and has different meanings in different social, legal, and moral frameworks. Popular perceptions often imagine the embryo as a little person in the earliest stages of development, although in reality, embryos can take various forms and not all of them develop into adults. The controversy surrounding the embryo and its moral, legal, and political implications is ongoing, especially with the emergence of modern technologies.
WHERE IS PROSTATE CANCER OCCURED?5 answersProstate cancer is most commonly diagnosed in Europe, North America, and Oceania, with the highest incidence rates in these regions. Incidence rates vary greatly between continents, with Northern and Western Europe having the highest rates and Asia having the lowest rates. Within continents, there is also considerable variation between countries. Prostate cancer screening has become prevalent in many countries since the 1990s, leading to an increase in incidence rates, particularly in the United States.
What is prostate cancer?4 answersProstate cancer is the most common cancer in males and affects a significant percentage of men during their lifetime. It is the most common malignancy among males worldwide and the second leading cause of cancer death among men in the United States. Prostate cancer is the most common internal malignancy in males and is ranked second in death due to cancer. It is currently the most common cancer diagnosed in males living in developed nations and is becoming more commonly encountered worldwide. Prostate cancer is the most common solid tumor malignancy among men in the western world.

See what other people are reading

What are the organs at risk for prostate bed VMAT?
5 answers
How does cold temperature affect the urinary tract and contribute to recurrent cystitis?
5 answers
What is the association between small cell neuroendocrine carcinoma of the urinary bladder and paraneoplastic syndrome?
4 answers
What is the association between small cell neuroendocrine carcinoma of the urinary bladder and paraneoplastic syndrome?
4 answers
What is the differential disease for penile swelling in elderly patients with indwelling urethral balloon catheters?
4 answers
What is the differential disease for penile swelling in elderly patients with indwelling urethral balloon catheters?
4 answers
What is the relationship between hpv infection and verrucous carcinoma of the urinary bladder?
5 answers
The relationship between HPV infection and verrucous carcinoma of the urinary bladder is a topic of ongoing debate. While some studies suggest a potential association between HPV and bladder cancer, including verrucous carcinoma, others indicate a lack of evidence supporting an etiologic role of HPV in bladder cancer development. Research has shown that HPV infection is prevalent in a notable percentage of bladder cancer cases, with a significant correlation between HPV infection and tumor stage, grade, muscle invasion, and recurrence in bladder cancer patients. Additionally, a study found a statistically significant relationship between HPV infection and urothelial carcinoma of the bladder, regardless of tumor grade, indicating a potential link between HPV and bladder cancer. Overall, while the exact relationship between HPV infection and verrucous carcinoma of the urinary bladder remains controversial, some evidence suggests a possible association.
How do these challenges vary depending on the type of bladder replacement procedure used?
5 answers
Challenges in bladder replacement procedures vary based on the technique utilized. Traditional methods involve incorporating detubularized bowel segments, leading to complications like loss of volitional voiding control. In contrast, tissue engineering aims to create functional bladder substitutes without relying on bowel tissue, addressing issues such as metabolic disturbances and chronic infections associated with enterocystoplasty. Studies on artificial urinary bladder design emphasize the need for bio-compatible materials that mimic human bladder functionality and ensure long-term safety and reliability. Additionally, ureteral reconstruction challenges primarily stem from iatrogenic injuries during gynecological, colorectal, or urological procedures, necessitating prompt recognition and repair to prevent postoperative complications like urine leaks. These insights highlight the diverse obstacles encountered in different bladder replacement approaches.
In which samples (tissue, blood, urine) is the BAT-26 biomarker present?
5 answers
The BAT-26 biomarker is present in tissue samples from various types of cancers. It has been detected in breast neoplasms and benign breast tumors, where microsatellite instability (MSI) at the BAT26 locus was observed. Additionally, BAT-26 mutations were studied in exfoliated urinary samples from patients with schistosomiasis-associated bladder cancer, showing a significant association with tumor stage and lymph node metastasis. However, a study on gallbladder carcinomas found no microsatellite instability at the BAT-26 marker in the tissue samples analyzed. Furthermore, the RER status of colorectal cancer tumors and cell lines was determined using BAT-26, showing distinct patterns in RER+ and RER- tumors. Therefore, BAT-26 is predominantly present in tissue samples from various cancer types for assessing microsatellite instability.
Can Entorhinal organoids be made from iPS cells?
5 answers
Entorhinal organoids can be derived from induced pluripotent stem cells (iPSCs). The generation of human cerebral organoids from iPSCs has revolutionized the modeling of aging human brains and related pathogenic processes. These organoids offer a reproducible method for studying brain aging, including age-related disorders, and identifying physiological and pathogenic mechanisms of human brain aging. Additionally, iPSC technology allows for the creation of organoids that mimic the structure and function of organs, such as alveolar organoids derived from iPSCs, which have been successfully used to study alveolar epithelial type II cells in the lung. Therefore, leveraging iPSCs for organoid generation presents a promising avenue for studying various organ systems, including the entorhinal region of the brain.
What is the advantages of technique of tumor en bloc resection affect the recovery time and overall patient experience?
5 answers
The technique of en bloc tumor resection offers several advantages that can positively impact recovery time and overall patient experience. En bloc resection provides intact tumor specimens, reducing the risk of tumor cell dissemination and facilitating accurate pathological assessment. This technique has been associated with higher rates of muscularis propria presence in histopathological specimens, leading to improved oncological outcomes. En bloc resection also results in shorter surgery and hospitalization times compared to conventional resection methods, potentially enhancing the overall patient experience. Moreover, en bloc resection techniques, whether using electric current or other modalities like laser or rotation-reversion, have shown effectiveness in achieving complete tumor removal with minimal complications, contributing to better recovery outcomes.